miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene
出版年份 2022 全文链接
标题
miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene
作者
关键词
miR-200c, Breast cancer, Doxorubicin, Chemosensitivity, MDR1
出版物
EXPERIMENTAL AND MOLECULAR PATHOLOGY
Volume 125, Issue -, Pages 104753
出版商
Elsevier BV
发表日期
2022-02-27
DOI
10.1016/j.yexmp.2022.104753
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR‐200c‐3p to upregulate ANLN
- (2020) Min Zhang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- The effect of combined miR‐200c replacement and cisplatin on apoptosis induction and inhibition of gastric cancer cell line migration
- (2019) Mehri Ghasabi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Diagnosis and Treatment of Breast Cancer in Young Women
- (2019) Lorenzo Rossi et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1
- (2018) Dawei Wu et al. CANCER GENE THERAPY
- Functional miRNAs in breast cancer drug resistance
- (2018) Weizi Hu et al. OncoTargets and Therapy
- miR-381 induces sensitivity of breast cancer cells to doxorubicin by inactivation of MAPK signaling via FYN
- (2018) Hailong Mi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Effect of miR-200c Inhibition on Chemosensitivity (5- FluoroUracil) in Colorectal Cancer
- (2017) Korosh Heydari et al. PATHOLOGY & ONCOLOGY RESEARCH
- Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin
- (2017) Sergio Rizzo et al. Oncotarget
- The role of microRNAs in colorectal cancer
- (2016) Ali Mohammadi et al. BIOMEDICINE & PHARMACOTHERAPY
- Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1
- (2016) Valentina Damiano et al. GENES CHROMOSOMES & CANCER
- miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance
- (2016) Merve Mutlu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Circulating miR-200c and miR-141 and outcomes in patients with breast cancer
- (2015) Silvia Antolín et al. BMC CANCER
- Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer
- (2015) Min-Ki Seong et al. BREAST CANCER RESEARCH AND TREATMENT
- MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer
- (2015) Eduardo Tormo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential
- (2015) J Knezevic et al. ONCOGENE
- miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment
- (2015) Shujing Liu et al. Pigment Cell & Melanoma Research
- A feedback regulatory loop involving p53/miR-200 and growth hormone endocrine axis controls embryo size of zebrafish
- (2015) Jing Jing et al. Scientific Reports
- miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression
- (2013) H. Tang et al. CLINICAL CANCER RESEARCH
- miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1
- (2012) Shujing Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression
- (2012) Florian Kopp et al. PLoS One
- p53 spreads out further: suppression of EMT and stemness by activating miR-200c expression
- (2011) Jörg Schubert et al. CELL RESEARCH
- p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
- (2011) Taewan Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
- (2011) Andreas Karakatsanis et al. MOLECULAR CARCINOGENESIS
- Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer
- (2010) P. Ceppi et al. MOLECULAR CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started